| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.061 | 0.2 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.037 | 0.2 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.3 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.058 | 0.3 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | 0.072 | 0.3 |